Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More


Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel... Read More


Yogesh Singh takes charge for second term as DU VC, first Indian to get reappointment

India, Oct. 8 -- Delhi University professor Yogesh Singh will begin his second term as Vice-Chancellor on Thursday, becoming the first Indian to serve two terms as the head of the varsity. Before Sin... Read More


In 2022, Louisiana backed a plan to reconnect the Mississippi River to its sinking coast and rebuild more than 13,000 acres of wetlands

India, Oct. 8 -- Imagine rebuilding a coastal shoreline by bringing back the river that helped form it. That idea underpinned the Mid-Barataria Sediment Diversion, a project emphasized by the U.S. Dep... Read More


IMF agreement clears path for $1.21bn Pakistan fundingPublished on: October 8, 2026 10:04 AM

Pakistan, Oct. 8 -- The International Monetary Fund has reached a staff-level agreement with Pakistan on the latest economic programme reviews. The agreement could unlock up to $1.21 billion in fresh ... Read More


Clinical Trial: Pulmonary Mechanics and Cerebral Oxygenation During Prone Lumbar Disc Surgery

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862257) titled 'Pulmonary Mechanics and Cerebral Oxygenation During Prone Lumbar Disc Surgery' on Oct. 01. ... Read More


Clinical Trial: Comparison of Post-Operative Sensitivity of 5th Genaration Bonding Agent With 8th Generation Bonding Agent in Class1 Composite Restoration

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862270) titled 'Comparison of Post-Operative Sensitivity of 5th Genaration Bonding Agent With 8th Generation... Read More


Clinical Trial: Testing Ultra-processed Warning Labels and Not-Ultra-processed Labels in United States

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863570) titled 'Testing Ultra-processed Warning Labels and Not-Ultra-processed Labels in United States' on O... Read More


Clinical Trial: Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863856) titled 'Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Co... Read More